These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 14985267)

  • 1. Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathies.
    Zhang G; Lopez PH; Li CY; Mehta NR; Griffin JW; Schnaar RL; Sheikh KA
    Brain; 2004 May; 127(Pt 5):1085-100. PubMed ID: 14985267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunobiology of Guillain-Barré syndromes.
    Willison HJ
    J Peripher Nerv Syst; 2005 Jun; 10(2):94-112. PubMed ID: 15958123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin G subclass distribution of autoantibodies to gangliosides in patients with Guillain-Barre syndrome.
    Ilyas AA; Chen ZW; Cook SD; Mithen FA; Singhal BS
    Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):115-23. PubMed ID: 11458979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An anti-ganglioside antibody-secreting hybridoma induces neuropathy in mice.
    Sheikh KA; Zhang G; Gong Y; Schnaar RL; Griffin JW
    Ann Neurol; 2004 Aug; 56(2):228-39. PubMed ID: 15293275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
    Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
    J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding.
    Jacobs BC; O'Hanlon GM; Bullens RW; Veitch J; Plomp JJ; Willison HJ
    Brain; 2003 Oct; 126(Pt 10):2220-34. PubMed ID: 12876146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-ganglioside antibodies and the presynaptic motor nerve terminal.
    Willison HJ; Plomp JJ
    Ann N Y Acad Sci; 2008; 1132():114-23. PubMed ID: 18567860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
    Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
    Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies.
    Odaka M; Yuki N; Tatsumoto M; Tateno M; Hirata K
    J Neurol; 2004 Jan; 251(1):24-9. PubMed ID: 14999485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to gangliosides and ganglioside complexes in Guillain-Barré syndrome and Fisher syndrome: mini-review.
    Kaida K; Kusunoki S
    J Neuroimmunol; 2010 Jun; 223(1-2):5-12. PubMed ID: 20172612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-GM1/GD1a complex antibodies in GBS sera specifically recognize the hybrid dimer GM1-GD1a.
    Mauri L; Casellato R; Ciampa MG; Uekusa Y; Kato K; Kaida K; Motoyama M; Kusunoki S; Sonnino S
    Glycobiology; 2012 Mar; 22(3):352-60. PubMed ID: 21921061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies against ganglioside complexes in Guillain-Barré syndrome and related disorders.
    Kusunoki S; Kaida K
    J Neurochem; 2011 Mar; 116(5):828-32. PubMed ID: 21214559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship.
    Funakoshi K; Koga M; Takahashi M; Hirata K; Yuki N
    J Neurol Sci; 2006 Jul; 246(1-2):163-8. PubMed ID: 16600306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic disialylgalactose immunoadsorbents deplete anti-GQ1b antibodies from autoimmune neuropathy sera.
    Willison HJ; Townson K; Veitch J; Boffey J; Isaacs N; Andersen SM; Zhang P; Ling CC; Bundle DR
    Brain; 2004 Mar; 127(Pt 3):680-91. PubMed ID: 14960498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-GM1 IgG antibodies induce leukocyte effector functions via Fcgamma receptors.
    van Sorge NM; van den Berg LH; Geleijns K; van Strijp JA; Jacobs BC; van Doorn PA; Wokke JH; van de Winkel JG; Leusen JH; van der Pol WL
    Ann Neurol; 2003 May; 53(5):570-9. PubMed ID: 12730990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
    Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
    Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guillain-Barré syndrome: update on immunobiology and treatment.
    Kaida K; Kusunoki S
    Expert Rev Neurother; 2009 Sep; 9(9):1307-19. PubMed ID: 19769446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-ganglioside complex antibodies associated with severe disability in GBS.
    Kaida K; Morita D; Kanzaki M; Kamakura K; Motoyoshi K; Hirakawa M; Kusunoki S
    J Neuroimmunol; 2007 Jan; 182(1-2):212-8. PubMed ID: 17113161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A common mechanism and a new categorization for anti-ganglioside antibody-mediated neuropathies.
    Uncini A
    Exp Neurol; 2012 Jun; 235(2):513-6. PubMed ID: 22507308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.